Management of chronic obstructive pulmonary disease: A review

Journal of Pharmacy Practice

Volumn 14, Issue 2, 2001, Pages 126-142

  Beauchesne, Marie France ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Bronchodilators; COPD; Corticosteroids

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE; IPRATROPIUM BROMIDE; OXITROPIUM BROMIDE; PREDNISOLONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TIOTROPIUM BROMIDE; TRIAMCINOLONE;

CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DRUG CHOICE; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; IMMUNIZATION; MUSCLE WEAKNESS; MYOPATHY; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHARMACEUTICAL CARE; QUALITY OF LIFE; RASH; REVIEW; SMOKING CESSATION; TACHYCARDIA; TREATMENT PLANNING; TREMOR; XEROSTOMIA;

EID: 0034977134     PISSN: 08971900     EISSN: None     Source Type: Journal    
DOI: 10.1106/777C-KD4J-YM5X-XW1M     Document Type: Review

References (62)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease
2. Chronic obstructive pulmonary disease
3. The impact of COPD on lung health worldwide
4. Exacerbations of COPD. Environmental mechanisms
5. Mechanisms in COPD. Differences from asthma
6. Critical appraisal of clinical practice guidelines targeting chronic obstructive pulmonary disease
7. National and International Guidelines for COPD. The need for evidence
8. Current concepts in pharmacologic management of chronic obstructive pulmonary disease
9. 1
10. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
11. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease
12. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: A randomised controlled trial
13. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: A placebo-controlled randomized trial
14. Long-term oxygen therapy
15. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxemia
16. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients
17. Indications for surgery and patient work-up for bullectomy
18. Lung transplantation
19. Lung transplantation comes of age
20. The registry of the international society for heart and lung transplantation: Twelfth official report, 1996
21. A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease
22. The spirometric efficacy of once daily dosing with tiotropium in stable COPD patients
23. Superior efficacy of once daily dosing with tiotropium compared to ipratropium as a maintenance treatment bronchodilator in COPD
24. Stable chronic obstructive pulmonary disease
25. Bronchodilator response in chronic obstructive pulmonary disease
26. Quality of life changes in COPD patients treated with salmeterol
27. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD)
28. Efficacy of salmeterol xinafoate in the treatment of COPD
29. In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial
30. Routine nebulized ipratropium and albuterol together are better than either agent alone in COPD
31. Addition of anticholinergic solution prolongs bronchodilator effect of beta-2-agonists in patients with chronic obstructive pulmonary disease
32. Bronchodilators in chronic airflow limitation: Effects on airway function, exercise capacity, and quality of life
33. A comparison of inhaled ipratropium, oral theophylline plus inhaled β-agonist, and the combination of all three in patients with COPD
34. Theophylline in Asthma
35. Analysis of inhaled corticosteroid and theophylline use among patients with stable COPD from 1987 to 1995
36. Prehospitalization inhaled corticosteroid use in patients with COPD or asthma
37. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomized controlled trial
38. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
39. Randomized, double-blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
40. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
41. Adverse effects of corticosteroid therapy for COPD: A critical review
42. A short course of corticosteroid therapy is as effective as a long course
43. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomized controlled trial
44. Bacterial infection in chronic obstructive pulmonary disease
45. The role of infection in COPD
46. Assessment of bronchodilator efficacy in symptomatic COPD. Is spirometry useful?
47. Toward a consensus definition for COPD exacerbations
48. COPD Exacerbation
49. Infectious etiology of acute exacerbations of chronic bronchitis
50. Antibiotic therapy in exacerbation of chronic obstructive lung disease
51. Antibiotics in chronic obstructive pulmonary disease exacerbation: A meta-analysis
52. Antimicrobial therapy for acute exacerbations of chronic bronchitis
53. Comparison of nebulized salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease
54. Comparison of one versus two bronchodilators in ventilated COPD patients
55. Effects of intravenously administered aminophylline on ventilation/perfusion inequality during recovery from exacerbations of chronic obstructive pulmonary disease
56. Theophylline for irreversible chronic airflow limitation: A randomized study comparing n of 1 trials to standard practice
57. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
58. Noninvasive ventilatory support does not facilitate recovery from acute respiratory failure in chronic obstructive pulmonary disease
59. "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: Prospective randomized controlled trial